Cargando…

Prognostic factors and survival of patients undergoing surgical intervention for breast cancer bone metastases

INTRODUCTION: Bone is the most common distant site of breast cancer metastasis. Skeletal lesions can cause significant morbidity due to pain, pathologic fracture, and electrolyte abnormalities. Current treatment for patients with bone metastases (BoM) from breast cancer is highly personalized and of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hankins, Margaret L., Smith, Clair N., Hersh, Beverly, Heim, Tanya, Belayneh, Rebekah, Dooley, Sean, Lee, Adrian V., Oesterreich, Steffi, Lucas, Peter C., Puhalla, Shannon L., Weiss, Kurt R., Watters, Rebecca J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8143999/ https://www.ncbi.nlm.nih.gov/pubmed/34040953 http://dx.doi.org/10.1016/j.jbo.2021.100363

Ejemplares similares

Detection of ESR1 mutations in circulating cell-free DNA from patients with metastatic breast cancer treated with palbociclib and letrozole
por: Gyanchandani, Rekha, et al.
Publicado: (2016)

To bind or not to bind - FoxA1 determines estrogen receptor action in breast cancer progression
por: Watters, Rebecca J, et al.
Publicado: (2012)

Zoledronic acid effectiveness against breast cancer metastases - a role for estrogen in the microenvironment?
por: Steinman, Richard A, et al.
Publicado: (2012)

Patient treatment and outcome after breast cancer orbital and periorbital metastases: a comprehensive case series including analysis of lobular versus ductal tumor histology
por: Blohmer, Martin, et al.
Publicado: (2020)

Tumor Resection Guided by Intraoperative Indocyanine Green Dye Fluorescence Angiography Results in Negative Surgical Margins and Decreased Local Recurrence in an Orthotopic Mouse Model of Osteosarcoma
por: Mahjoub, Adel, et al.
Publicado: (2018)

Mutation site and context dependent effects of ESR1 mutation in genome-edited breast cancer cell models
por: Bahreini, Amir, et al.
Publicado: (2017)

26th Annual San Antonio Breast Cancer Symposium, San Antonio, Texas, USA, 3–6 December 2003: update on preclinical and translational research
por: Lee, Adrian V, et al.
Publicado: (2004)

Targeted mutation detection in breast cancer using MammaSeq™
por: Smith, Nicholas G., et al.
Publicado: (2019)

The molecular landscape of premenopausal breast cancer
por: Liao, Serena, et al.
Publicado: (2015)

Estradiol as a Targeted, Late-Line Therapy in Metastatic Breast Cancer with Estrogen Receptor Amplification
por: Kota, Karthik, et al.
Publicado: (2017)

Estrogen-repressed genes – key mediators of estrogen action?
por: Zubairy, Simeen, et al.
Publicado: (2005)

Precision Medicine in Hormone Receptor-Positive Breast Cancer
por: Nasrazadani, Azadeh, et al.
Publicado: (2018)

Effects of socioeconomic status and race on survival and treatment in metastatic breast cancer
por: Puthanmadhom Narayanan, Susrutha, et al.
Publicado: (2023)

Ixabepilone: a new chemotherapeutic option for refractory metastatic breast cancer
por: Puhalla, Shannon, et al.
Publicado: (2008)

BRCA 1/2-Mutation Related and Sporadic Breast and Ovarian Cancers: More Alike than Different
por: Burgess, Melissa, et al.
Publicado: (2014)

Sustained, Long-Term Maintenance of Remission with Single-Agent Veliparib in Recurrent Triple-Negative Breast Cancer
por: Kota, Karthik, et al.
Publicado: (2017)

The Werner syndrome helicase protein is required for cell proliferation, immortalization, and tumorigenesis in Scaffold Attachment Factor B1 deficient mice
por: Lachapelle, Sophie, et al.
Publicado: (2011)

Progestins: Pro-senescence therapy for ovarian cancer?
por: Oesterreich, Steffi, et al.
Publicado: (2013)

Non-coding single nucleotide variants affecting estrogen receptor binding and activity
por: Bahreini, Amir, et al.
Publicado: (2016)

FGFR4 overexpression and hotspot mutations in metastatic ER+ breast cancer are enriched in the lobular subtype
por: Levine, Kevin M., et al.
Publicado: (2019)

Network-guided prediction of aromatase inhibitor response in breast cancer
por: Ruffalo, Matthew, et al.
Publicado: (2019)

RET signaling in breast cancer therapeutic resistance and metastasis
por: Pecar, Geoffrey, et al.
Publicado: (2023)

A Case of Late-Onset Gemcitabine Lung Toxicity
por: Sherrod, Amanda M., et al.
Publicado: (2011)

Unique integrated stress response sensors regulate cancer cell susceptibility when Hsp70 activity is compromised
por: Sannino, Sara, et al.
Publicado: (2021)

Improving ChIP-seq peak-calling for functional co-regulator binding by integrating multiple sources of biological information
por: Osmanbeyoglu, Hatice Ulku, et al.
Publicado: (2012)

The role of single nucleotide polymorphisms in breast cancer metastasis
por: Rae, James M, et al.
Publicado: (2008)

Epigenetics in breast cancer: what's new?
por: Huang, Yi, et al.
Publicado: (2011)

Mapping molecular subtype specific alterations in breast cancer brain metastases identifies clinically relevant vulnerabilities
por: Cosgrove, Nicola, et al.
Publicado: (2022)

Scaffold attachment factor B2 (SAFB2)-null mice reveal non-redundant functions of SAFB2 compared with its paralog, SAFB1
por: Jiang, Shiming, et al.
Publicado: (2015)

Semi-deconvolution of bulk and single-cell RNA-seq data with application to metastatic progression in breast cancer
por: Lei, Haoyun, et al.
Publicado: (2022)

The Scaffold attachment factor b1 (Safb1) regulates myogenic differentiation by facilitating the transition of myogenic gene chromatin from a repressed to an activated state
por: Hernández-Hernández, J. Manuel, et al.
Publicado: (2013)

Postoperative delirium in patients undergoing surgery for bone metastases
por: Hindiskere, Suraj, et al.
Publicado: (2020)

Functional Interaction of Histone Deacetylase 5 (HDAC5) and Lysine-specific Demethylase 1 (LSD1) Promotes Breast Cancer Progression
por: Cao, Chunyu, et al.
Publicado: (2016)

Mutual exclusivity of ESR1 and TP53 mutations in endocrine resistant metastatic breast cancer
por: Li, Zheqi, et al.
Publicado: (2022)

Avenues of research in dietary interventions to target tumor metabolism in osteosarcoma
por: Leite, Taiana Campos, et al.
Publicado: (2021)

WNT4 mediates estrogen receptor signaling and endocrine resistance in invasive lobular carcinoma cell lines
por: Sikora, Matthew J., et al.
Publicado: (2016)

Transcriptome Characterization of Matched Primary Breast and Brain Metastatic Tumors to Detect Novel Actionable Targets
por: Varešlija, Damir, et al.
Publicado: (2018)

How Researchers, Clinicians and Patient Advocates Can Accelerate Lobular Breast Cancer Research
por: Pate, Leigh, et al.
Publicado: (2021)

Acquired mutations and transcriptional remodeling in long-term estrogen-deprived locoregional breast cancer recurrences
por: Priedigkeit, Nolan, et al.
Publicado: (2021)

Scaffold attachment factor B1 (SAFB1) heterozygosity does not influence Wnt-1 or DMBA-induced tumorigenesis
por: Kaipparettu, Benny Abraham, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_htd0revv40j95cq8nsgsuncgja